Table 1.
Insulin sensitizers | |
Metformin (Biguanide) | |
Thiazolidines (Pioglitazone, Rosiglitazone) | |
Antioxidants | |
Vitamin E | |
Vitamin C | |
Polyphenols (Resveratrol, etc.) | |
Hepatocyte-protective agents | |
Ursodeoxycholic acid | |
n-3 polyunsaturated fatty acids (EPA and DHA) | |
Antidyslipidemia | |
Statins | |
Fibrates | |
NPC1L1 inhibitors (ezetimibe) | |
RAS blockers | |
Angiotensin II receptor blockers | |
Angiotensin-converting enzyme inhibitors | |
Antialdosterone (spironolactone and eplerenone) | |
Renin inhibitor (aliskiren) | |
Incretin-related agents | |
GLP-1 agonists/analogs (exenatide and liraglutide) | |
DPP-4 inhibitors (sitagliptin and vildagliptin) | |
Antiobesity drugs | |
Orlistat | |
Sibutramine | |
Mazindol |